HSBC Holdings’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-13,258
Closed -$358K 2679
2022
Q4
$358K Buy
13,258
+2,816
+27% +$68.9K ﹤0.01% 2440
2022
Q3
$232K Sell
10,442
-3,728
-26% -$97.4K ﹤0.01% 2551
2022
Q2
$387K Sell
14,170
-1,614
-10% -$46.4K ﹤0.01% 2484
2022
Q1
$530K Buy
15,784
+5,505
+54% +$177K ﹤0.01% 2375
2021
Q4
$353K Buy
10,279
+3,014
+41% +$97.4K ﹤0.01% 2666
2021
Q3
$229K Sell
7,265
-1,259
-15% -$42.7K ﹤0.01% 2705
2021
Q2
$308K Buy
8,524
+3,792
+80% +$157K ﹤0.01% 2496
2021
Q1
$207K Buy
+4,732
New +$222K ﹤0.01% 2533
2020
Q4
Sell
-6,429
Closed -$216K 3032
2020
Q3
$216K Sell
6,429
-2,467
-28% -$78.8K ﹤0.01% 2424
2020
Q2
$261K Sell
8,896
-3,163
-26% -$91.6K ﹤0.01% 2199
2020
Q1
$323K Sell
12,059
-99
-0.8% -$2.96K ﹤0.01% 2015
2019
Q4
$415K Sell
12,158
-1,898
-14% -$68.7K ﹤0.01% 2329
2019
Q3
$526K Sell
14,056
-292
-2% -$11.1K ﹤0.01% 2311
2019
Q2
$625K Buy
14,348
+4,007
+39% +$171K ﹤0.01% 1967
2019
Q1
$441K Sell
10,341
-4,486
-30% -$201K ﹤0.01% 2166
2018
Q4
$664K Buy
14,827
+1,626
+12% +$85.2K ﹤0.01% 1986
2018
Q3
$905K Buy
13,201
+7,606
+136% +$489K ﹤0.01% 1799
2018
Q2
$320K Sell
5,595
-6,635
-54% -$351K ﹤0.01% 2253
2018
Q1
$564K Sell
12,230
-22
-0.2% -$1.04K ﹤0.01% 1889
2017
Q4
$566K Sell
12,252
-1,646
-12% -$75.7K ﹤0.01% 1466
2017
Q3
$626K Buy
13,898
+591
+4% +$25.2K ﹤0.01% 1647
2017
Q2
$522K Buy
13,307
+2,880
+28% +$109K ﹤0.01% 1680
2017
Q1
$397K Sell
10,427
-13,716
-57% -$534K ﹤0.01% 1688
2016
Q4
$893K Buy
24,143
+7,463
+45% +$267K ﹤0.01% 1467
2016
Q3
$578K Sell
16,680
-26
-0.2% -$911 ﹤0.01% 1525
2016
Q2
$543K Sell
16,706
-1,365
-8% -$41.8K ﹤0.01% 1543
2016
Q1
$519K Buy
18,071
+476
+3% +$12.7K ﹤0.01% 1534
2015
Q4
$588K Sell
17,595
-225
-1% -$7K ﹤0.01% 1635
2015
Q3
$507K Sell
17,820
-394
-2% -$13.7K ﹤0.01% 1396
2015
Q2
$737K Sell
18,214
-11,227
-38% -$504K ﹤0.01% 1318
2015
Q1
$1.45M Sell
29,441
-10,885
-27% -$504K ﹤0.01% 1258
2014
Q4
$1.83M Buy
+40,326
New +$1.58M ﹤0.01% 1182

Other funds holding AVNS